Mice with endothelial cell‐selective adhesion molecule deficiency develop coronary microvascular rarefaction and left ventricle diastolic dysfunction

Abstract Endothelial cell‐selective adhesion molecule (ESAM) regulates inflammatory cell adhesion and transmigration and promotes angiogenesis. Here, we examined the role of ESAM in cardiac vascularization, inflammatory cell infiltration, and left ventricle (LV) diastolic function under basal and he...

Full description

Bibliographic Details
Published in:	Physiological Reports
Main Authors:	Vadym Buncha, Katie Anne Fopiano, Liwei Lang, Celestine Williams, Anatolij Horuzsko, Jessica Andrea Filosa, Gaston Kapuku, Zsolt Bagi
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Subjects:	angiogenesis coronary diastolic dysfunction HFpEF inflammation
Online Access:	https://doi.org/10.14814/phy2.15643

Similar Items

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
by: Clement Lau, et al.
Published: (2022-07-01)

Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis
by: Domenico D'Amario, et al.
Published: (2024-08-01)

Chloroquine improves left ventricle diastolic function in streptozotocin-induced diabetic mice
by: Yuan X, et al.
Published: (2016-08-01)

Diastolic Cardiac Function by MRI—Imaging Capabilities and Clinical Applications
by: El-Sayed H. Ibrahim, et al.
Published: (2021-12-01)

The assessment of left ventricular diastolic function: guidance and recommendations from the British Society of Echocardiography
by: Shaun Robinson, et al.
Published: (2024-06-01)

The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
by: Becker Al-Khayatt, et al.
Published: (2024-05-01)

Heart failure with preserved ejection fraction: diagnostic value of HFA-PEFF score, H₂FPEF score, and the diastolic stress echocardiography
by: Andrzej Kubicius, et al.
Published: (2024-10-01)

Sacubitril/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice
by: Nozomi Furukawa, et al.
Published: (2024-10-01)

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition
by: Paula Ketilly Nascimento Alves, et al.
Published: (2023-11-01)

Dantrolene improves left ventricular diastolic property in mineralcorticoid-salt-induced hypertensive rats
by: Junya Nawata, et al.
Published: (2023-07-01)

Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodelling
by: Mandy O. J. Grootaert, et al.
Published: (2025-02-01)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
by: James P. Teuber, et al.
Published: (2022-09-01)

Impact of epicardial adipose tissue on cardiac function and morphology in patients with diastolic dysfunction
by: Alexander Schulz, et al.
Published: (2024-08-01)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
by: Bin Dong, et al.
Published: (2022-11-01)

POCUS for Diastolic Dysfunction: A Review of the Literature
by: Samantha King, et al.
Published: (2023-04-01)

Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies
by: Francesca Coppi, et al.
Published: (2025-06-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01)

Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction
by: Shiro Hoshida, et al.
Published: (2022-06-01)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
by: Michiel T.H.M. Henkens, et al.
Published: (2022-06-01)

Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction
by: Jan Verwerft, et al.
Published: (2024-08-01)

Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway
by: Xinyu Hu, et al.
Published: (2025-08-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
by: Nicole Habel, et al.
Published: (2023-06-01)

Clinical profile of heart failure in geriatric patients in a tertiary cardiac hospital of Bangladesh
by: Mahbuba Yesmin, et al.
Published: (2025-06-01)

Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial
by: Kramer J. Wahlberg, et al.
Published: (2024-01-01)

Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism
by: Payman Zamani, et al.
Published: (2021-08-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
by: Yohei Sotomi, et al.
Published: (2021-06-01)

Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors
by: Akshat Agrawal, et al.
Published: (2025-07-01)

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility
by: Volker Adams, et al.
Published: (2022-06-01)

Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study
by: Jerremy Weerts, et al.
Published: (2025-07-01)

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF
by: Paula Ketilly Nascimento Alves, et al.
Published: (2024-03-01)

A Comprehensive Profile of Heart Failure Patients Across Ejection Fraction Subtypes: Insights from a Single-Center Retrospective Cohort Study
by: Austėja Kaunaitė, et al.
Published: (2025-08-01)

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia
by: Kengo Ayabe, et al.
Published: (2024-10-01)

Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
by: Elisabeth A. Jalink, et al.
Published: (2024-01-01)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
by: José M. Inácio, et al.
Published: (2023-07-01)

Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models
by: Sarah Huang, et al.
Published: (2024-10-01)

Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
by: Stephanie J. Rowe, BBiomed, MD, et al.
Published: (2025-01-01)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
by: Karolina Andrzejczyk, et al.
Published: (2024-06-01)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
by: Jenni Huusko, et al.
Published: (2019-08-01)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
by: Arjun K. Pandey, et al.
Published: (2022-04-01)